{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:23:42Z","timestamp":1766755422625,"version":"3.48.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C99-167"],"award-info":[{"award-number":["TSGH-C99-167"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-C-108-074"],"award-info":[{"award-number":["TSGH-C-108-074"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-E-109220"],"award-info":[{"award-number":["TSGH-E-109220"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MAB-104-089"],"award-info":[{"award-number":["MAB-104-089"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MAB-108-074"],"award-info":[{"award-number":["MAB-108-074"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 107-2314-B-016-001-"],"award-info":[{"award-number":["MOST 107-2314-B-016-001-"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-016-046"],"award-info":[{"award-number":["MOST 111-2314-B-016-046"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC111-2314-B-016 -019 -MY3"],"award-info":[{"award-number":["NSTC111-2314-B-016 -019 -MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"DOI":"10.1007\/s00223-025-01435-0","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:07:02Z","timestamp":1760710022000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Differential Impact of Interferon-Based and Direct-Acting Antiviral Therapies on Bone Metabolism in Chronic Hepatitis C: Insights from Transcriptomic and Clinical Analyses"],"prefix":"10.1007","volume":"116","author":[{"given":"Yi-Lin","family":"Chiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tsai-Yuan","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Juei","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tien-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Hung","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-Chuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang-Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Ting","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Feng","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I-Hsuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bao-Chung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsuan-Hwai","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Lueng","family":"Shih","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-Ju","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5059-8766","authenticated-orcid":false,"given":"Jung-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"1435_CR1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/s00198-021-05827-4","volume":"32","author":"J Powell","year":"2021","unstructured":"Powell J, Michael A (2021) Peri-operative derangement in liver function tests in older patients with neck of femur fracture. Osteoporos Int 32:1027\u20131030","journal-title":"Osteoporos Int"},{"key":"1435_CR2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12967-024-04941-1","volume":"22","author":"Z Lu","year":"2024","unstructured":"Lu Z, Li X, Qi Y, Li B, Chen L (2024) Genetic evidence of the causal relationship between chronic liver diseases and musculoskeletal disorders. J Transl Med 22:138","journal-title":"J Transl Med"},{"key":"1435_CR3","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00223-012-9653-y","volume":"91","author":"JC Lin","year":"2012","unstructured":"Lin JC, Hsieh TY, Wu CC, Chen PJ, Chueh TH, Chang WK, Chu HC (2012) Association between chronic hepatitis C virus infection and bone mineral density. Calcif Tissue Int 91:423\u2013429","journal-title":"Calcif Tissue Int"},{"key":"1435_CR4","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00223-024-01204-5","volume":"114","author":"Y Liu","year":"2024","unstructured":"Liu Y, Yuan M, He J, Cai L, Leng A (2024) The impact of non-alcohol fatty liver disease on bone mineral density is mediated by sclerostin by Mendelian randomization study. Calcif Tissue Int 114:502\u2013512","journal-title":"Calcif Tissue Int"},{"key":"1435_CR5","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00223-014-9884-1","volume":"95","author":"S Mora","year":"2014","unstructured":"Mora S, Giacomet V, Vigan\u00f2 A, Maruca K, Capelli S, Nannini P, Zuccotti GV (2014) Areal bone mineral density in pediatric patients with chronic hepatitis B or chronic hepatitis C. Calcif Tissue Int 95:218\u2013221","journal-title":"Calcif Tissue Int"},{"key":"1435_CR6","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002239900622","volume":"64","author":"OM Crosbie","year":"1999","unstructured":"Crosbie OM, Freaney R, McKenna MJ, Hegarty JE (1999) Bone density, vitamin D status, and disordered bone remodeling in end-stage chronic liver disease. Calcif Tissue Int 64:295\u2013300","journal-title":"Calcif Tissue Int"},{"key":"1435_CR7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s002239900545","volume":"63","author":"A Bagur","year":"1998","unstructured":"Bagur A, Mautalen C, Findor J, Sorda J, Somoza J (1998) Risk factors for the development of vertebral and total skeleton osteoporosis in patients with primary biliary cirrhosis. Calcif Tissue Int 63:385\u2013390","journal-title":"Calcif Tissue Int"},{"key":"1435_CR8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s002239900205","volume":"60","author":"A Monegal","year":"1997","unstructured":"Monegal A, Navasa M, Gua\u00f1abens N, Peris P, Pons F, Martinez de Osaba MJ, Rimola A, Rod\u00e9s J, Mu\u00f1oz-G\u00f3mez J (1997) Osteoporosis and bone mineral metabolism disorders in cirrhotic patients referred for orthotopic liver transplantation. Calcif Tissue Int 60:148\u2013154","journal-title":"Calcif Tissue Int"},{"key":"1435_CR9","first-page":"213","volume":"21","author":"T Wang","year":"2020","unstructured":"Wang T, He C (2020) TNF-\u03b1 and IL-6: the link between immune and bone system. Curr Drug Targets 21:213\u2013227","journal-title":"Curr Drug Targets"},{"key":"1435_CR10","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.2147\/JIR.S283768","volume":"13","author":"HW Chen","year":"2020","unstructured":"Chen HW, Chiu YL, Hsieh TY, Chen PJ, Huang TY, Lin HH, Shih YL, Lin JC (2020) Relationships between vitamin D status and cytokine: results from interferon-based therapy in non-cirrhotic, treatment-na\u00efve patients with chronic hepatitis C infection. J Inflamm Res 13:1207\u20131218","journal-title":"J Inflamm Res"},{"key":"1435_CR11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174608","volume":"12","author":"P Komolmit","year":"2017","unstructured":"Komolmit P, Charoensuk K, Thanapirom K, Suksawatamnuay S, Thaimai P, Chirathaworn C, Poovorawan Y (2017) Correction of vitamin D deficiency facilitated suppression of IP-10 and DPP IV levels in patients with chronic hepatitis C: a randomised double-blinded, placebo-control trial. PLoS ONE 12:e0174608","journal-title":"PLoS ONE"},{"key":"1435_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s00223-009-9249-3","volume":"85","author":"FA Pereira","year":"2009","unstructured":"Pereira FA, Facincani I, Jorgetti V, Ramalho LNZ, Volpon JB, dos Reis LM, de Paula FJA (2009) Etiopathogenesis of hepatic osteodystrophy in Wistar rats with cholestatic liver disease. Calcif Tissue Int 85:75\u201383","journal-title":"Calcif Tissue Int"},{"key":"1435_CR13","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00223-001-2028-4","volume":"69","author":"M Ninkovic","year":"2001","unstructured":"Ninkovic M, Love SA, Tom B, Alexander GJM, Compston JE (2001) High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int 69:321\u2013326","journal-title":"Calcif Tissue Int"},{"key":"1435_CR14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/BF00298990","volume":"57","author":"MA Valero","year":"1995","unstructured":"Valero MA, Loinaz C, Larrodera L, Leon M, Moreno E, Hawkins F (1995) Calcitonin and bisphosphonates treatment in bone loss after liver transplantation. Calcif Tissue Int 57:15\u201319","journal-title":"Calcif Tissue Int"},{"key":"1435_CR15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.aidm.2014.11.001","volume":"2","author":"T-M Chen","year":"2015","unstructured":"Chen T-M, Huang P-T, Show B-C, Wen C-F, Chen Y-P (2015) Impact of interleukin-28B polymorphism on HCV-1 infected patients treated with response-guided therapy. Adv Digest Med 2:25\u201332","journal-title":"Adv Digest Med"},{"key":"1435_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s11901-013-0172-8","volume":"12","author":"C-F Huang","year":"2013","unstructured":"Huang C-F, Chuang W-L, Yu M-L (2013) The evolution of HCV treatment in Taiwan. Curr Hepat Rep 12:143\u2013148","journal-title":"Curr Hepat Rep"},{"key":"1435_CR17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s12519-017-0013-x","volume":"13","author":"A Megahed","year":"2017","unstructured":"Megahed A, Salem N, Fathy A, Barakat T, Alsayed MAEL, Mabood SAE, Zalata KR, Abdalla AF (2017) Pegylated interferon \u03b1\/ribavirin therapy enhances bone mineral density in children with chronic genotype 4 HCV infection. World J Pediatr 13:346\u2013352","journal-title":"World J Pediatr"},{"key":"1435_CR18","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-014-2663-z","volume":"25","author":"E Redondo-Cerezo","year":"2014","unstructured":"Redondo-Cerezo E, Casado-Caballero F, Martin-Rodriguez JL, Hernandez-Quero J, Escobar-Jimenez F, Gonzalez-Calvin JL (2014) Bone mineral density and bone turnover in non-cirrhotic patients with chronic hepatitis C and sustained virological response to antiviral therapy with peginterferon-alfa and ribavirin. Osteoporos Int 25:1709\u20131715","journal-title":"Osteoporos Int"},{"key":"1435_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/BF02383532","volume":"11","author":"T Miki","year":"1993","unstructured":"Miki T, Yoshida H, Shioi A, Jono S, Yoshino M, Nakatsuka K, Hagiwara S, Kawagishi T, Nishizawa Y, Morii H (1993) Effect of interferon \u03b1 on calcium and bone metabolism in patients with chronic hepatitis. J Bone Miner Metab 11:39\u201344","journal-title":"J Bone Miner Metab"},{"key":"1435_CR20","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1365-2893.2008.01038.x","volume":"15","author":"WP Hofmann","year":"2008","unstructured":"Hofmann WP, Kronenberger B, Bojunga J, Stamm B, Herrmann E, B\u00fccker A, Mihm U, von Wagner M, Zeuzem S, Sarrazin C (2008) Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy. J Viral Hepat 15:790\u2013796","journal-title":"J Viral Hepat"},{"key":"1435_CR21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.apjtb.2016.11.027","volume":"7","author":"V Babaei","year":"2017","unstructured":"Babaei V, Ghorbani M, Mohseni N, Afraid H, Saghaei Y, Teimourian S (2017) Clinical correlations between chronic hepatitis C infection and decreasing bone mass density after treatment with interferon-alpha. Asian Pac J Trop Biomed 7:161\u2013165","journal-title":"Asian Pac J Trop Biomed"},{"key":"1435_CR22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0168-8278(00)80314-1","volume":"33","author":"JA Sol\u00eds-Herruzo","year":"2000","unstructured":"Sol\u00eds-Herruzo JA, Castellano G, Fern\u00e1ndez I, Mu\u00f1oz R, Hawkins F (2000) Decreased bone mineral density after therapy with alpha interferon in combination with ribavirin for chronic hepatitis c. J Hepatol 33:812\u2013817","journal-title":"J Hepatol"},{"key":"1435_CR23","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00223-004-0175-0","volume":"75","author":"RO Moreira","year":"2004","unstructured":"Moreira RO, Baldu\u00edno A, Martins HSLH, Reis JSN, Duarte MEL, Farias MLF, Borojevic R (2004) Ribavirin, but not interferon \u03b1-2b, is associated with impaired osteoblast proliferation and differentiation in vitro. Calcif Tissue Int 75:160\u2013168","journal-title":"Calcif Tissue Int"},{"key":"1435_CR24","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00223-023-01135-7","volume":"113","author":"GP Arcidiacono","year":"2023","unstructured":"Arcidiacono GP, Poci C, Sella S, Torres MO, Zanchetta F, Cecchinato A, Diogo M, Peleg Falb M, Giannini S (2023) Hepatitis C-associated osteosclerosis (HCAO): long-term follow-up of a new case recovered after antiviral treatment. Calcif Tissue Int 113:571\u2013577","journal-title":"Calcif Tissue Int"},{"key":"1435_CR25","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(18)32111-1","volume":"393","author":"F Carrat","year":"2019","unstructured":"Carrat F, Fontaine H, Dorival C, Simony M, Diallo A, Hezode C, De Ledinghen V, Larrey D, Haour G, Bronowicki JP, Zoulim F, Asselah T, Marcellin P, Thabut D, Leroy V, Tran A, Habersetzer F, Samuel D, Guyader D, Chazouilleres O, Mathurin P, Metivier S, Alric L, Riachi G, Gournay J, Abergel A, Cales P, Ganne N, Loustaud-Ratti V, D\u2019Alteroche L, Causse X, Geist C, Minello A, Rosa I, Gelu-Simeon M, Portal I, Raffi F, Bourliere M, Pol S (2019) Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study. Lancet 393:1453\u20131464","journal-title":"Lancet"},{"key":"1435_CR26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3892\/br.2022.1567","volume":"17","author":"T Ichikawa","year":"2022","unstructured":"Ichikawa T, Yamashima M, Yamamichi S, Koike M, Nakano Y, Honda T, Yajima H, Miyazaki O, Kuribayashi Y, Ikeda T, Okamura T, Nakao K (2022) Direct-acting antiviral treatment decreases serum undercarboxylated osteocalcin in male patients with chronic hepatitis C. Biomed Rep 17:84","journal-title":"Biomed Rep"},{"key":"1435_CR27","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciaa1396","volume":"73","author":"A Carrero","year":"2021","unstructured":"Carrero A, Berenguer J, Honta\u00f1\u00f3n V, Guardiola JM, Navarro J, von Wichmann MA, T\u00e9llez MJ, Quereda C, Santos I, Sanz J, Galindo MJ, Hern\u00e1ndez-Quero J, Jim\u00e9nez-Sousa MA, P\u00e9rez-Latorre L, Bell\u00f3n JM, Resino S, Esteban H, Mart\u00ednez E, Gonz\u00e1lez-Garc\u00eda J (2021) Effects of hepatitis C virus (HCV) eradication on bone mineral density in human immunodeficiency virus\/HCV-coinfected patients. Clin Infect Dis 73:e2026\u2013e2033","journal-title":"Clin Infect Dis"},{"key":"1435_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s41100-023-00500-4","volume":"9","author":"MM Elnokeety","year":"2023","unstructured":"Elnokeety MM, Darwish RA, Hegazy MT, Abouzeid S, Fayed A (2023) The impact of HCV eradication using interferon-free direct acting antivirals on bone-mineral, anemia parameters and peripheral insulin resistance in hepatitis c-infected Egyptian hemodialysis cohort. Renal Replace Ther 9:49","journal-title":"Renal Replace Ther"},{"key":"1435_CR29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s00223-021-00822-7","volume":"109","author":"MC de Camargo Vieira","year":"2021","unstructured":"de Camargo Vieira MC, Gon\u00e7alves WRB, Guerra RA, Callegaro FS, Lazaretti-Castro M, Maeda SS (2021) Hepatitis C-associated osteosclerosis: improvement after treatment with sofosbuvir, daclatasvir, and ibandronate: case report and literature review. Calcif Tissue Int 109:104\u2013109","journal-title":"Calcif Tissue Int"},{"key":"1435_CR30","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/JVI.02640-06","volume":"81","author":"MW Taylor","year":"2007","unstructured":"Taylor MW, Tsukahara T, Brodsky L, Schaley J, Sanda C, Stephens MJ, McClintick JN, Edenberg HJ, Li L, Tavis JE, Howell C, Belle SH (2007) Changes in gene expression during pegylated interferon and ribavirin therapy of chronic hepatitis C virus distinguish responders from nonresponders to antiviral therapy. J Virol 81:3391\u20133401","journal-title":"J Virol"},{"key":"1435_CR31","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1172\/JCI75938","volume":"124","author":"EG Meissner","year":"2014","unstructured":"Meissner EG, Wu D, Osinusi A, Bon D, Virtaneva K, Sturdevant D, Porcella S, Wang H, Herrmann E, McHutchison J, Suffredini AF, Polis M, Hewitt S, Prokunina-Olsson L, Masur H, Fauci AS, Kottilil S (2014) Endogenous intrahepatic IFNs and association with IFN-free HCV treatment outcome. J Clin Invest 124:3352\u20133363","journal-title":"J Clin Invest"},{"key":"1435_CR32","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","volume":"131","author":"HS Conjeevaram","year":"2006","unstructured":"Conjeevaram HS, Fried MW, Jeffers LJ, Terrault NA, Wiley-Lucas TE, Afdhal N, Brown RS, Belle SH, Hoofnagle JH, Kleiner DE, Howell CD (2006) Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1. Gastroenterology 131:470\u2013477","journal-title":"Gastroenterology"},{"key":"1435_CR33","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1001\/jama.2013.109309","volume":"310","author":"A Osinusi","year":"2013","unstructured":"Osinusi A, Meissner EG, Lee YJ, Bon D, Heytens L, Nelson A, Sneller M, Kohli A, Barrett L, Proschan M, Herrmann E, Shivakumar B, Gu W, Kwan R, Teferi G, Talwani R, Silk R, Kotb C, Wroblewski S, Fishbein D, Dewar R, Highbarger H, Zhang X, Kleiner D, Wood BJ, Chavez J, Symonds WT, Subramanian M, McHutchison J, Polis MA, Fauci AS, Masur H, Kottilil S (2013) Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial. JAMA 310:804\u2013811","journal-title":"JAMA"},{"key":"1435_CR34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s00198-017-4257-z","volume":"29","author":"SH Ahn","year":"2018","unstructured":"Ahn SH, Seo DH, Kim SH, Nam MS, Hong S (2018) The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010\u20132011. Osteoporos Int 29:181\u2013190","journal-title":"Osteoporos Int"},{"key":"1435_CR35","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s00198-023-06996-0","volume":"35","author":"L Zeng","year":"2024","unstructured":"Zeng L, Li Y, Hong C, Wang J, Zhu H, Li Q, Cui H, Ma P, Li R, He J, Zhu H, Liu L, Xiao L (2024) Association between fatty liver index and controlled attenuation parameters as markers of metabolic dysfunction-associated fatty liver disease and bone mineral density: observational and two-sample Mendelian randomization studies. Osteoporos Int 35:679\u2013689","journal-title":"Osteoporos Int"},{"key":"1435_CR36","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00198-023-06760-4","volume":"34","author":"EC Hill","year":"2023","unstructured":"Hill EC, O\u2019Donnell L (2023) Low bone mineral density is associated with fatty liver disease and respiratory illness in a pediatric mortality sample. Osteoporos Int 34:1231\u20131239","journal-title":"Osteoporos Int"},{"key":"1435_CR37","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1007\/s00198-024-07217-y","volume":"35","author":"J Tao","year":"2024","unstructured":"Tao J, Li H, Wang H, Tan J, Yang X (2024) Metabolic dysfunction-associated fatty liver disease and osteoporosis: the mechanisms and roles of adiposity. Osteoporos Int 35:2087\u20132098","journal-title":"Osteoporos Int"},{"key":"1435_CR38","doi-asserted-by":"crossref","DOI":"10.4110\/in.2018.18.e8","volume":"18","author":"DS Amarasekara","year":"2018","unstructured":"Amarasekara DS, Yun H, Kim S, Lee N, Kim H, Rho J (2018) Regulation of osteoclast differentiation by cytokine networks. Immune Netw 18:e8","journal-title":"Immune Netw"},{"issue":"Suppl 3","key":"1435_CR39","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1186\/ar581","volume":"4","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Taniguchi T (2002) Signaling crosstalk between RANKL and interferons in osteoclast differentiation. Arthritis Res 4(Suppl 3):S227-232","journal-title":"Arthritis Res"},{"key":"1435_CR40","first-page":"469","volume":"30","author":"S Avnet","year":"2007","unstructured":"Avnet S, Cenni E, Perut F, Granchi D, Brandi ML, Giunti A, Baldini N (2007) Interferon-alpha inhibits in vitro osteoclast differentiation and renal cell carcinoma-induced angiogenesis. Int J Oncol 30:469\u2013476","journal-title":"Int J Oncol"},{"key":"1435_CR41","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1002\/jcp.23009","volume":"227","author":"VJ Woeckel","year":"2012","unstructured":"Woeckel VJ, Eijken M, van de Peppel J, Chiba H, van der Eerden BC, van Leeuwen JP (2012) IFN\u03b2 impairs extracellular matrix formation leading to inhibition of mineralization by effects in the early stage of human osteoblast differentiation. J Cell Physiol 227:2668\u20132676","journal-title":"J Cell Physiol"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-025-01435-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-025-01435-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T13:20:55Z","timestamp":1766755255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-025-01435-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1007\/s00223-025-01435-0","relation":{},"ISSN":["1432-0827"],"issn-type":[{"type":"electronic","value":"1432-0827"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"15 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Yi-Lin Chiu, Tsai-Yuan Hsieh, Yu-Juei Hsu, Tien-Yu Huang, Chang Hung Liao, Meng-Chuan Lu, Fang-Chen Liu, Yi-Ting Chou, Chao-Feng Chang, I-Hsuan Huang, Bao-Chung Chen, Hsuan-Hwai Lin, Yu-Lueng Shih, Yun-Ju Yang, and Jung-Chun Lin declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the Institutional Review Board (protocol numbers: 098-05-068, 1-107-05-095, and A202005006) at the Tri-Service General Hospital, Taipei, Taiwan. Written informed consent was obtained from all the participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional\nand\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical\nstandards. The study was approved by the Institutional Review Board of the Tri-Service General Hospital, Taipei, Taiwan (Protocol\nnumbers: 098\u201305-068, 1-107-05-095, and A202005006). Written informed consent was obtained from all individual participants\nincluded in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights"}}],"article-number":"129"}}